Leap Therapeutics (LPTX) Misses Q3 EPS by 8c

Leap Therapeutics (NASDAQ: LPTX) reported Q3 EPS of ($0.08).

For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• DA Davidson Reiterates Underperform Rating on c3.ai (AI)